Literature DB >> 12798627

Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes.

Rabie M Mohamed1, Fumie Aosai, Mei Chen, Hye-Seong Mun, Kazumi Norose, Usama S Belal, Lian-Xun Piao, Akihiko Yano.   

Abstract

The vaccination with Toxoplasma gondii heat shock protein 70 (T.g.HSP70) gene (a virulent tachyzoite-specific) induced the most prominent reduction in T. gondii loads in various organs of B6 and BALB/c mice at the acute and chronic phases of toxoplasmosis compared with T.g.HSP30 (a bradyzoite-specific) and SAG1 (a tachyzoite-specific) genes. A single gene gun vaccination with 2 microg of T.g.HSP70 gene induced a significant reduction in the number of T. gondii organisms compared with 50 microg of T.g.HSP70 gene vaccination by intramuscular (i.m.) or intraperitoneal (i.p.) injection. The vaccine effects of T.g.HSP70 gene persisted for more than 3 months.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798627     DOI: 10.1016/s0264-410x(03)00157-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  Conservation of Babesia bovis small heat shock protein (Hsp20) among strains and definition of T helper cell epitopes recognized by cattle with diverse major histocompatibility complex class II haplotypes.

Authors:  Junzo Norimine; Juan Mosqueda; Guy H Palmer; Harris A Lewin; Wendy C Brown
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Differential subcellular localization of members of the Toxoplasma gondii small heat shock protein family.

Authors:  N de Miguel; P C Echeverria; S O Angel
Journal:  Eukaryot Cell       Date:  2005-12

3.  Molecular cloning and characterization of a cytosolic heat shock protein 70 from Naegleria fowleri.

Authors:  Kyoung-Ju Song; Kyung-Hui Song; Byoung-Kuk Na; Jong-Hyun Kim; Daeho Kwon; Sun Park; Jhang-Ho Pak; Kyung-Il Im; Ho-Joon Shin
Journal:  Parasitol Res       Date:  2007-01-25       Impact factor: 2.289

4.  Effect of rSAG-1(P30) immunisation on the circulating and tissue parasites in guinea pigs as determined by quantitative PCR.

Authors:  Pierre Flori; Laëtitia Tardy; Alain Jacquet; Bahrie Bellete; Jamal Hafid; Hélène Raberin; Roger Tran Manh Sung
Journal:  Parasitol Res       Date:  2006-01-17       Impact factor: 2.289

Review 5.  The role of small heat shock proteins in parasites.

Authors:  Deyanira Pérez-Morales; Bertha Espinoza
Journal:  Cell Stress Chaperones       Date:  2015-06-05       Impact factor: 3.667

6.  Toxoplasma gondii infection inhibits the mitochondrial apoptosis through induction of Bcl-2 and HSP70.

Authors:  Il-Young Hwang; Juan Hua Quan; Myoung-Hee Ahn; Hassan Ahmed Hassan Ahmed; Guang-Ho Cha; Dae-Whan Shin; Young-Ha Lee
Journal:  Parasitol Res       Date:  2010-08-03       Impact factor: 2.289

7.  Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4.

Authors:  Fumie Aosai; Martha S Rodriguez Pena; Hye-Seong Mun; Hao Fang; Tetsuya Mitsunaga; Kazumi Norose; Hyun Kyu Kang; Yoe-Sik Bae; Akihiko Yano
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

8.  Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.

Authors:  Valentina Martin; Alicia Supanitsky; Pablo C Echeverria; Silvana Litwin; Tamara Tanos; Adolfo R De Roodt; Eduardo A Guarnera; Sergio O Angel
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

9.  The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice.

Authors:  Mona M El Temsahy; Eman D H El Kerdany; Maha M Eissa; Thanaa I Shalaby; Iman M Talaat; Nermine M F H Mogahed
Journal:  J Parasit Dis       Date:  2014-09-05

10.  Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.

Authors:  Young-Ha Lee; Dae-Whan Shin; Jae-Ho Lee; Ho-Woo Nam; Myoung-Hee Ahn
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.